Attovia Therapeutics, Inc. (ATTO) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 8, 2026.
- Filings shown
- 14
- Open-market buys
- 9
- Open-market sells
- 46
- Buys, 10b5-1 box not checked
- 9 of 9
Counts cover the 14 most recent Form 4 filings Tradune holds for ATTO (filed Aug 6 – Oct 8, 2026). SEC EDGAR Form 4 filings for ATTO last checked Nov 22, 2026, 09:00 UTC; the latest ATTO filing Tradune holds was filed Oct 8, 2026. This is not guaranteed to be the complete record — see ATTO's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 4 filings Tradune holds for ATTO filed Aug 28 – Oct 8, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
46 open-market sales by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 0 sales· 0 sh
- checkbox disclosed
- On filings with the box not checked
- 46 sales· 211,614 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold |
|---|---|---|---|---|
| Goldman Sachs Group IncInsider | 2 | 23 | 585,000 | 105,807 |
| Colin WalshDirector | 2 | 23 | 585,000 | 105,807 |
Dollar value: value undisclosed — at least one Form 4 in this window has no complete disclosed value, so totals are not shown.
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at ATTO
Insiders reported 9 open-market purchases of ATTO between Aug 6, 2026 and Oct 8, 2026, across 6 distinct buyers. The most recent purchase was reported by Frazier Life Sciences Xi, L.P. (10% owner) on Aug 6, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 140,000 | — | — | — | Aug 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 538,300 | — | — | — | Aug 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 1,957,134 | — | 2,042,134 (indirect) | +2,303% | Aug 6, 2026 |
| Conversion of derivative | 478,498 | — | 2,520,632 (indirect) | +23% | Aug 6, 2026 |
| Open-market purchase 10b5-1 box not checked | 500,000 | $17.00 | 3,020,632 (indirect) | +20% | Aug 6, 2026 |
| Conversion of derivative Series B Preferred Stock | 18,181,830 | — | — | — | Aug 6, 2026 |
| Conversion of derivative Series C Preferred Stock | 4,445,275 | — | — | — | Aug 6, 2026 |
| Open-market sale 10b5-1 box not checked | 200 | $22.05 | 82,033 (indirect) | −0.2% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 1,556 | $22.06 | 80,477 (indirect) | −1.9% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 3,402 | $22.02 | 77,075 (indirect) | −4.2% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 200 | $22.10 | 76,875 (indirect) | −0.3% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 480 | $21.55 | 76,395 (indirect) | −0.6% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 100 | $22.11 | 76,295 (indirect) | −0.1% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 753 | $21.97 | 75,542 (indirect) | −1.0% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 672 | $22.02 | 74,870 (indirect) | −0.9% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 400 | $22.02 | 67,500 (indirect) | −0.6% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 1,180 | $21.84 | 66,320 (indirect) | −1.7% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 1,040 | $22.05 | 65,280 (indirect) | −1.6% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 300 | $20.84 | 64,980 (indirect) | −0.5% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 443 | $21.78 | 64,537 (indirect) | −0.7% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 200 | $22.05 | 64,337 (indirect) | −0.3% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 700 | $22.07 | 63,637 (indirect) | −1.1% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 1,163 | $22.19 | 62,474 (indirect) | −1.8% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 100 | $21.99 | 62,374 (indirect) | −0.2% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 6,763 | $21.61 | 55,611 (indirect) | −11% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 76,418 | $21.04 | 0 (indirect) | −100% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 6,970 | $22.03 | 67,900 (indirect) | −9.3% | Aug 5, 2026 |
| Open-market purchase 10b5-1 box not checked | 85,000 | $21.00 | 85,000 (indirect) | — | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 988 | $22.03 | 84,012 (indirect) | −1.2% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 447 | $21.87 | 83,565 (indirect) | −0.5% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 1,332 | $22.03 | 82,233 (indirect) | −1.6% | Aug 5, 2026 |
| Derivative purchase Equity Swap | 2,872 | $21.22 | — | — | Aug 5, 2026 |
| Derivative purchase Equity Swap | 28,717 | $21.22 | — | — | Aug 5, 2026 |
| Derivative purchase Equity Swap | 11,488 | $21.22 | — | — | Aug 5, 2026 |
| Derivative purchase Equity Swap | 45,588 | $21.27 | — | — | Aug 5, 2026 |
| Derivative purchase Equity Swap | 11,398 | $21.27 | — | — | Aug 5, 2026 |
| Derivative purchase Equity Swap | 5,744 | $21.22 | — | — | Aug 5, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 1,957,134 | — | 2,042,134 (indirect) | +2,303% | Aug 6, 2026 |
| Open-market purchase 10b5-1 box not checked | 500,000 | $17.00 | 3,020,632 (indirect) | +20% | Aug 6, 2026 |
| Conversion of derivative Series B Preferred Stock | 18,181,830 | — | — | — | Aug 6, 2026 |
| Conversion of derivative Series C Preferred Stock | 4,445,275 | — | — | — | Aug 6, 2026 |
| Conversion of derivative | 478,498 | — | 2,520,632 (indirect) | +23% | Aug 6, 2026 |
| Open-market purchase 10b5-1 box not checked | 85,000 | $21.00 | 85,000 (indirect) | — | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 988 | $22.03 | 84,012 (indirect) | −1.2% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 447 | $21.87 | 83,565 (indirect) | −0.5% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 1,332 | $22.03 | 82,233 (indirect) | −1.6% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 200 | $22.05 | 82,033 (indirect) | −0.2% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 1,556 | $22.06 | 80,477 (indirect) | −1.9% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 3,402 | $22.02 | 77,075 (indirect) | −4.2% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 200 | $22.10 | 76,875 (indirect) | −0.3% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 480 | $21.55 | 76,395 (indirect) | −0.6% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 100 | $22.11 | 76,295 (indirect) | −0.1% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 753 | $21.97 | 75,542 (indirect) | −1.0% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 672 | $22.02 | 74,870 (indirect) | −0.9% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 6,970 | $22.03 | 67,900 (indirect) | −9.3% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 400 | $22.02 | 67,500 (indirect) | −0.6% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 1,180 | $21.84 | 66,320 (indirect) | −1.7% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 1,040 | $22.05 | 65,280 (indirect) | −1.6% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 300 | $20.84 | 64,980 (indirect) | −0.5% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 443 | $21.78 | 64,537 (indirect) | −0.7% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 200 | $22.05 | 64,337 (indirect) | −0.3% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 700 | $22.07 | 63,637 (indirect) | −1.1% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 1,163 | $22.19 | 62,474 (indirect) | −1.8% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 100 | $21.99 | 62,374 (indirect) | −0.2% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 6,763 | $21.61 | 55,611 (indirect) | −11% | Aug 5, 2026 |
| Open-market sale 10b5-1 box not checked | 76,418 | $21.04 | 0 (indirect) | −100% | Aug 5, 2026 |
| Derivative purchase Equity Swap | 2,872 | $21.22 | — | — | Aug 5, 2026 |
| Derivative purchase Equity Swap | 28,717 | $21.22 | — | — | Aug 5, 2026 |
| Derivative purchase Equity Swap | 11,488 | $21.22 | — | — | Aug 5, 2026 |
| Derivative purchase Equity Swap | 45,588 | $21.27 | — | — | Aug 5, 2026 |
| Derivative purchase Equity Swap | 11,398 | $21.27 | — | — | Aug 5, 2026 |
| Derivative purchase Equity Swap | 5,744 | $21.22 | — | — | Aug 5, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 1,957,138 | — | 1,957,138 | — | Aug 6, 2026 |
| Conversion of derivative Series C Redeemable Convertible Preferred Stock | 18,181,818 | — | — | — | Aug 6, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 382,352 | $17.00 | 4,181,367 | +10% | Aug 6, 2026 |
| Conversion of derivative Series A Preferred Stock | 21,477,273 | — | — | — | Aug 6, 2026 |
| Conversion of derivative Series B Preferred Stock | 7,636,362 | — | — | — | Aug 6, 2026 |
| Conversion of derivative Series C Preferred Stock | 6,179,219 | — | — | — | Aug 6, 2026 |
| Conversion of derivative | 2,311,870 | — | 2,311,870 | — | Aug 6, 2026 |
| Conversion of derivative | 821,998 | — | 3,133,868 | +36% | Aug 6, 2026 |
| Conversion of derivative | 665,147 | — | 3,799,015 | +21% | Aug 6, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 782,855 | — | 782,855 (indirect) | — | Aug 6, 2026 |
| Open-market purchase 10b5-1 box not checked | 300,000 | $17.00 | 1,082,855 (indirect) | +38% | Aug 6, 2026 |
| Conversion of derivative Series C Preferred Stock | 782,855 | — | — | — | Aug 6, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 782,854 | — | 782,854 (indirect) | — | Aug 6, 2026 |
| Open-market purchase 10b5-1 box not checked | 200,000 | $17.00 | 982,854 | +26% | Aug 6, 2026 |
| Open-market purchase 10b5-1 box not checked | 400,000 | $17.00 | 1,182,854 (indirect) | +51% | Aug 6, 2026 |
| Conversion of derivative Series B Preferred Stock | 782,854 | — | — | — | Aug 6, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative Series B Preferred Stock | 11,054,544 | — | — | — | Aug 6, 2026 |
| Conversion of derivative Series A-1 Preferred Stock | 16,250,000 | — | — | — | Aug 6, 2026 |
| Conversion of derivative Series C Preferred Stock | 8,930,685 | — | — | — | Aug 6, 2026 |
| Open-market purchase 10b5-1 box not checked | 588,235 | $17.00 | 6,154,213 | +11% | Aug 6, 2026 |
| Conversion of derivative | 961,322 | — | 5,565,978 | +21% | Aug 6, 2026 |
| Conversion of derivative | 1,189,940 | — | 4,604,656 | +35% | Aug 6, 2026 |
| Conversion of derivative | 1,590,175 | — | 3,414,716 | +87% | Aug 6, 2026 |
| Conversion of derivative | 1,749,192 | — | 1,824,541 | +2,321% | Aug 6, 2026 |
| Conversion of derivative Series A-2 Preferred Stock | 14,772,727 | — | — | — | Aug 6, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 140,000 | — | — | — | Aug 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 140,000 | — | — | — | Aug 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 140,000 | — | — | — | Aug 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 27,000 | — | — | — | Aug 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Option (Right to Buy) | 27,000 | — | — | — | Aug 4, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to ATTO's (Oct 8, 2026).
Frequently asked about ATTO insider activity
How many insiders bought ATTO stock in these Form 4 filings?
6 distinct insiders at Attovia Therapeutics, Inc. reported 9 open-market purchases (Form 4 code P) of ATTO shares between Aug 6, 2026 and Oct 8, 2026, the most recent filed by Frazier Life Sciences Xi, L.P. (10% owner) on Aug 6, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for ATTO?
The most recent Form 4 on this page was filed by Tao Fu (President and CEO) on Oct 8, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market ATTO insider purchase shown?
The largest open-market purchase among the filings shown was 588,235 ATTO shares at $17.00 (about $9,999,995) by Frazier Life Sciences Xi, L.P. (10% owner) on Aug 6, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent ATTO insider purchases have the Form 4 10b5-1 box checked?
No. All 9 ATTO open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Frazier Life Sciences Xi, L.P. (10% owner) on Aug 6, 2026, 588,235 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for ATTO — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.